- Open Access
Response to: A brief comment on the predictive value of myeloperoxidase-conjugated DNA level in patients with septic shock
© The Author(s). 2018
- Received: 7 November 2018
- Accepted: 20 November 2018
- Published: 18 December 2018
The original article was published in Critical Care 2018 22:294
We read the letter from Li et al. with great interest. We appreciate their thoughtful comments and would like to address some of their concerns regarding our recently published article  in Critical Care.
Their first question was related to comorbidities and treatments. Thirty-two of our patients (58%) had at least one comorbidity, with frequent comorbidities being heart disease (28%), chronic obstructive pulmonary disease (14%), diabetes (13%), chronic kidney disease (8%), and cancer (4%). We agree that these comorbidities and treatments such as anticoagulants (discussed below) or fluid resuscitation may affect the plasma level of neutrophil extracellular traps (NETs) . However, neutrophil activation and NET formation during sepsis would be much more prominent than in other inflammatory diseases, including atherosclerosis, deep vein thrombosis, ischemic heart disease, and collagen diseases. For example, the maximum plasma level of cell-free DNA (cf-DNA) was reported to be higher in ICU patients with infection than in other ICU patients .
The second issue they raised was the basis for selecting the assessment time points. Organ failure parameters obtained on day 1 and parameters of disseminated intravascular coagulation (DIC) obtained on day 3 were excluded from the “Results” section, but were presented in Additional files 1 and 2, respectively. On day 1, the plasma levels of MPO-DNA and cf-DNA were not correlated with parameters of coagulation or organ failure. Innate immunity, including phagocytosis and release of NETs, is the first line of defense against invading pathogens, but excessive NET formation leads to endothelial cell damage. Thus, an appropriate level of NET formation during the early stage of septic shock is required to reduce bacterial spread and prevent organ damage, but the “appropriate” plasma levels of MPO-DNA and cf-DNA remain unclear.
Finally, they raised the lack of a correlation between the DIC score and NET formation. Absence of a correlation between the plasma NET level and DIC score does not refute the immunothrombosis hypothesis proposed by Kambas  because anticoagulant therapy (antithrombin, recombinant thrombomodulin, protease inhibitors, etc.) is often performed for DIC in Japan. Such therapy would have influenced the findings of our study. Antithrombin administration was reported to reduce pulmonary NET formation due to lipopolysaccharide-induced endotoxemia , while serine protease inhibitors and recombinant thrombomodulin  also inhibit NET formation in vitro. In conclusion, we await further clinical studies exploring the role of NETs in the development of septic DIC.
Availability of data and materials
Writing the manuscript: NT. Critical revision: NT. The author read and approved the final manuscript.
Ethics approval and consent to participate
Consent for publication
The author declares that he has no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Maruchi Y, Tsuda M, Mori H, et al. Plasma myeloperoxidase-conjugated DNA level predicts outcomes and organ dysfunction in patients with septic shock. Crit Care. 2018;22:176.View ArticleGoogle Scholar
- Brinkmann V. Neutrophil extracellular traps in the second decade. J Innate Immun. 2018:1–8. https://doi.org/10.1159/000489829.
- Saukkonen K, Lakkisto P, Varpula M, et al. Association of cell-free plasma DNA with hospital mortality and organ dysfunction in intensive care unit patients. Intensive Care Med. 2007;33:1624.View ArticleGoogle Scholar
- Kambas K, Mitroulis I, Ritis K. The emerging role of neutrophils in thrombosis—the journey of TF through NETs. Front Immunol. 2012;3:385.View ArticleGoogle Scholar
- Ishikawa M, Yamashita H, Oka N, et al. Antithrombin III improved neutrophil extracellular traps in lung after the onset of endotoxemia. J Surg Res. 2017;208:140.View ArticleGoogle Scholar
- Shimomura Y, Suga M, Kuriyama N, et al. Recombinant human thrombomodulin inhibits neutrophil extracellular trap formation in vitro. J Intensive Care. 2016;4:48.View ArticleGoogle Scholar